OrthoPediatrics, which sells orthopedic devices specialized for children, raised $52 million by offering 4.0 million shares at $13, at the midpoint of the $12 to $14 range. At pricing, the company commands a fully diluted market cap of $157 million. OrthoPediatrics plans to list on the Nasdaq under the symbol KIDS. Piper Jaffray and Stifel acted as lead managers on the deal.
